An Evaluation of Aranesp® in Subjects With Anaemic Chronic Kidney Disease (CKD)

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Kidney Disease
Interventions
DRUG

Aranesp® (darbepoetin alfa)

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY